Ureidopenicillin
WikiDoc Resources for Ureidopenicillin |
Articles |
---|
Most recent articles on Ureidopenicillin Most cited articles on Ureidopenicillin |
Media |
Powerpoint slides on Ureidopenicillin |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Ureidopenicillin at Clinical Trials.gov Trial results on Ureidopenicillin Clinical Trials on Ureidopenicillin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Ureidopenicillin NICE Guidance on Ureidopenicillin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Ureidopenicillin Discussion groups on Ureidopenicillin Patient Handouts on Ureidopenicillin Directions to Hospitals Treating Ureidopenicillin Risk calculators and risk factors for Ureidopenicillin
|
Healthcare Provider Resources |
Causes & Risk Factors for Ureidopenicillin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
The ureidopenicillins are a group of penicillins which are active against Pseudomonas aeruginosa. There are three ureidopenicillins in clinical use:
They are mostly ampicillin derivatives in which the D-side amino chain has been converted to a variety of ureas. It is speculated that the added side chain mimics a longer segment of the peptidoglycan chain, more than ampicillin, and thus would bind more easily to the penicillin-binding proteins. Ureidopenicillins are not resistant to beta-lactamases.
They are used parenterally, and are particularly indicated in infections caused by Gram-negative bacteria.